Product Search |
|
| Input Product Name Or Cas No. |
Category |
Products |
2-((anthracen-9-ylmethoxy)carbonyl)-4-(4 |
4-bromo-1,3,2-dioxathiolane 2,2-dioxide |
4-Vinylbenzyl methacrylate |
5-(hydroxymethyl)adamantan-2-yl methacry |
Octahydro-2-hydroxy-1,3-dioxo-1H-isoindo |
2-(1-Cyclohexyl-2,2,2-trifluoroethoxy)-2 |
triphenylsulfonium 4-hydroxybenzoate |
6-(methacryloyloxy)decahydro-1,4:5,8-dim |
1,2-Oxathiane, 3,3,4,4-tetrafluoro-, 2,2 |
Methyl N-(3-bromophenyl)carbamate |
1,4-Dideoxyhexitol |
3-(tert-butyl)-5-cyclopentyl-4-hydroxybe |
4-hydroxy-2,6-diisopropylbenzoic acid |
4-hydroxy-3-isopropyl-5-propylbenzoic ac |
3-[(1-Methylcyclohexyl)oxy]benzoic acid |
2-[(1-Methylcyclopentyl)oxy]benzoic acid |
4-[(1-Methylcyclopentyl)oxy]benzoic acid |
3-Methoxy-4-[(1-methylcyclopentyl)oxy]be |
Ethyl 4-[(4,4,5,5-tetramethyl-1,3,2-diox |
Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxa |
(3,5-dimethyl-4-((4,4,5,5,6,6,7,7,7-nona |
(4-(2-(adamantan-1-yl)acetoxy)-3,5-dimet |
(4-(2-(adamantan-1-yl)acetoxy)-3,5-dimet |
(4-hydroxy-3,5-dimethylphenyl)(phenyl)(t |
bis(4-(tert-butyl)phenyl)(trifluoromethy |
(4-(2-(adamantan-1-yloxy)-2-oxoethoxy)-3 |
(3,5-dimethyl-4-(2-oxo-2-((2-oxotetrahyd |
1-(4-(2-methoxy-2-oxoethoxy)naphthalen-1 |
(4-(2-acetoxyacetoxy)-3,5-dimethylphenyl |
(4-methoxy-3,5-dimethylphenyl)(phenyl)(t |
(4-(2-methoxy-2-oxoethoxy)-3,5-dimethylp |
(3,5-dimethyl-4-(((trifluoromethyl)sulfo |
(4-(2-(adamantan-1-yl)acetoxy)-3,5-dimet |
diphenyl(p-tolyl)sulfonium 1,1-difluoro- |
(4-(2-((1-ethylcyclohexyl)oxy)-2-oxoetho |
(3,5-dimethyl-4-(2-oxo-2-((4-oxoadamanta |
(3,5-dimethyl-4-(2-(2-((2-methyladamanta |
(4-(2-(tert-butoxy)-2-oxoethoxy)-3,5-dim |
(4-((adamantane-1-carbonyl)oxy)-3,5-dime |
(4-((adamantane-1-carbonyl)oxy)-3,5-dime |
1,3,5-Tris(2-phenylethenyl)-1,3,5-triazi |
1,3-Bis(methoxymethyl)-5-methyl-1,3,5-tr |
1,3-Di-2-propen-1-yl-1,3-diazetidine-2,4 |
1,3,5-Tri-4-pyridinyl-1,3,5-triazine-2,4 |
1,3,5-Tris(2-nitrophenyl)-1,3,5-triazine |
1,3,5-Tris[(acetyloxy)methyl]-1,3,5-tria |
1,3,5-Tris(chloromethyl)-1,3,5-triazine- |
1,3-Dibutyl-1,3-diazetidine-2,4-dione |
1-(Hydroxymethyl)-1,3,5-triazine-2,4,6(1 |
1,3,5-Tris(3-nitrophenyl)-1,3,5-triazine |
|
Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| Rovathin600 | 2,7-Dibromo-9,9-diethylfluorene | 197969-58-7 | 97% |
| RovathinS694 | 2,7-Dibromo-9,9-diphenylfluorene | 186259-63-2 | 97% |
| Rovathin601 | 1-Pyrenylboronic acid | 164461-18-1 | 97% |
| Rovathin602 | 9H-Fluoren-9-ol, 2,7-dibromo-9-phenyl- | 132717-37-4 | 97% |
| Rovathin603 | 9,10-Bis(2-naphthyl)anthracene | 122648-99-1 | 97% |
| Rovathin604 | Fluoren-2-amine, 9,9-dimethyl- | 108714-73-4 | 97% |
| Rovathin605 | 2-Bromo-9,9-dimethylfluorene | 28320-31-2 | 97% |
| Rovathin606 | 1-Amino-4-fluoronaphthalene | 438-32-4 | 97% |
| RovathinS701 | 9-Bromo-10-(naphthyl-2-yl)anthracene | 474688-73-8 | 97% |
| RovathinS702 | 2,7-Dibromo-9,9-dimethylfluorene | 28320-32-3 | 97% |
| RovathinS703 | 10,10'-Dibromo-9,9'-bianthryl | 121848-75-7 | 97% |
| Rovathin607 | Buflomedil Hydrochloride | 35543-24-9 | EP |
| Rovathin608 | Nisoldipine | 63675-72-9 | JP/CP |
| Rovathin609 | Ozagrel hydrochloride | 78712-43-3 | JP/CP |
| Rovathin610 | Atracurium Besylate | 64228-81-5 | BP2004/USP28 |
| Rovathin611 | Bupivacaine hydrochloride | 14252-80-3 | USP29/EP |
| Rovathin612 | (S)-(-)-Bupivacaine hydrochloride | 27262-48-2 | USP29 |
| Rovathin613 | (S)-(-)-Bupivacaine hydrochloride | 27262-48-2 | 98% |
| Rovathin614 | Ropivacaine hydrochloride | 98717-15-8 | USP29 |
| Rovathin615 | Adefovir Dipivoxil | 142340-99-6 | |
| Rovathin616 | diisopropylamine dichloroacetate | 660-27-5 | JP |
| Rovathin617 | Amifostine | 20537-88-6 | USP29 |
| Rovathin618 | Folinic acid, calcium salt | 1492-18-8 | USP29 |
| Rovathin619 | Calcium levofolinate | 80433-71-2 | EP |
| Rovathin620 | cisplatin | 15663-27-1 | USP |
| Rovathin621 | Cytarabine | 69-74-9 | USP |
| Rovathin622 | Docetaxel | 114977-28-5 | 98% |
| Rovathin623 | Etoposide | 33419-42-0 | USP |
| Rovathin624 | Gemcitabine hydrochloride | 122111-03-9 | USP28 |
| Rovathin625 | Imatinib | 220127-57-1 | |
|
|
|
|